Pharmaceutical intermediates
Levosimendan Intermediates
1 pharmaceutical intermediate for Levosimendan. Indication: Heart failure.
About Levosimendan
- Originator
- Orion Corporation
- Indication
- Heart failure
- Approved Date
- 09/22/2000
Available intermediates
1 intermediate currently listed for Levosimendan. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| 6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone | 36725-28-7 | / | / |
Building toward Levosimendan?
Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →